Relationships between changes in leptin and insulin resistance levels in obese individuals following weight loss  by Wang, Tsu-Nai et al.
Kaohsiung Journal of Medical Sciences (2013) 29, 436e443Available online at www.sciencedirect.com
journal homepage: http: / /www.kjms-onl ine.comORIGINAL ARTICLERelationships between changes in leptin and
insulin resistance levels in obese individuals
following weight lossTsu-Nai Wang a, Wen-Tsan Chang b, Yu-Wen Chiu c, Chun-Ying Lee d,
Kun-Der Lin e, Yu Yao Cheng f, Yi-Ju Su f,g, Hsin-Fang Chung h,
Meng-Chuan Huang g,h,*a Faculty of Public Health, Kaohsiung Medical University, Kaohsiung, Taiwan
bDepartment of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical
University, Kaohsiung, Taiwan
cDepartment of Family Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
dDepartment of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical
University, Kaohsiung, Taiwan
eDepartment of Endocrinology and Metabolism, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, Kaohsiung, Taiwan
fDepartment of Health and Nutrition, Chia-Nan University of Pharmacy and Science, Tainan,
Taiwan
gDepartment of Nutrition and Dietetics, Kaohsiung Medical University Hospital, Kaohsiung
Medical University, Kaohsiung, Taiwan
hDepartment of Public Health and Environmental Medicine, College of Medicine, Kaohsiung
Medical University, Kaohsiung, TaiwanReceived 6 February 2012; accepted 30 August 2012
Available online 18 February 2013KEYWORDS
Ghrelin;
Insulin resistance;
Leptin;
Polyunsaturates;* Corresponding author. Department
Medical University Hospital, Kaohsiun
E-mail address: mechhu@kmu.edu
1607-551X/$36 Copyright ª 2012, Kao
http://dx.doi.org/10.1016/j.kjms.201Abstract Obesity can augment insulin resistance (IR), leading to increased risk of diabetes
and heart disease. Leptin, ghrelin, and various fatty acids present in the cell membrane
may modulate IR. In this study, we aimed to investigate the impact of weight loss on IR, serum
leptin/ghrelin levels, and erythrocyte fatty acids, and studied the associations between
changes in these variables. A total of 35 obese (body mass index  27) adults participatedof Public Health and Environmental Medicine, Faculty of Medicine, College of Medicine, Kaohsiung
g Medical University, 100, Shi-Chuan 1st Road, Kaohsiung 807, Taiwan.
.tw (M.-C. Huang).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
2.08.041
Changes in leptin and HOMA-IR levels after weight loss 437Weight control in a weight loss program for 3 months. IR was assessed using homeostasis model assessment for
insulin resistance (HOMA-IR). The obese participants had a mean weight loss of 5.6  3.8 kg
followed by a 16.7% and 23.3% reduction in HOMA-IR and leptin (p < 0.001) levels, and an
11.3% increase in ghrelin levels (p Z 0.005). The level of erythrocyte saturates decreased
by 2.8%, while the level of ne3 polyunsaturates increased by 16.8% (all p < 0.05). The changes
in leptin levels (5.63 vs. 1.57 ng/mL) were significantly different (pZ 0.004) in those with
improved IR (changes in HOMA-IR < 0) than those without improvement (changes in HOMA-
IR  0), though there were no differences in the changes of ghrelin (p Z 0.120) and erythro-
cyte fatty acids (all p > 0.05) levels. After adjusting for age, gender, changes in ghrelin, and
body fat, we found a significant correlation between decreases in leptin and less risk of no
improvement in HOMA-IR levels [odds ratio (OR)Z 0.69, pZ 0.039]. In conclusion, a moderate
weight reduction in obese participants over a short period significantly improved IR. This
weight reduction concomitantly decreased serum leptin, increased ghrelin, and elevated some
erythrocyte unsaturates. Only leptin correlated independently with IR improvement upon
multivariable logistic regression analysis, which indicates that leptin may play a role in the
modulation of IR following weight loss.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Obesity and its associated metabolic pathologies affect
30e50% of the adult population worldwide, depending on
the area studied [1,2]. Increased consumption of energy-
dense food induces obesity, which increases the risk of
insulin resistance (IR), type 2 diabetes, coronary heart
diseases, and cancer [3]. Results of various studies suggest
that 5e10% weight loss can improve IR and other metabolic
risk factors in both adults [4e6] and children [7].
Levels of leptin, an adipokine produced by the adipose
tissue, are higher in obese adults than in lean ones [8], and this
state is commonly referred to as leptin resistance. Leptin
resistance occurs during the early stages of obesity and greatly
influences the metabolism of muscle fatty acids and insulin
sensitivity [9]. In contrast, circulating ghrelin level, a hormone
produced by the stomach, is lower in obese individuals [10].
Altering the circulating levels of leptin and ghrelin influences
appetite and energy balance in obese people, and they are
involved inthedevelopmentof IRandvasculardamage[10e12].
The fatty acid compositions in the membrane phospho-
lipids of insulin-targeted tissues play important roles in
modulating insulin sensitivity [13,14]. Human and animal
studies have reported positive correlations between long-
chain polyunsaturates and insulin sensitivity [13e16].
However, obese adults and adolescents have decreased
blood levels of longer-chain polyunsaturates (C20eC22),
especially the ne3 series, but increased levels of saturates
[15,16]. Diet supplementation with ne3 polyunsaturates is
reported to improve several metabolic factors, including IR,
in obese individuals [17].
Based on these findings, both circulating leptin and
ghrelin as well as certain fatty acids may contribute to the
development of IR [9,10]. To date, very few studies have
investigated the effects of weight loss on changes in IR
along with changes in blood leptin/ghrelin levels and fatty
acid composition in obese individuals. This study investi-
gated these relationships in obese individuals participating
in a dietitian-led weight loss program, and further explored
whether there might be an association between changes inleptin/ghrelin levels and the composition of erythrocyte
fatty acids and improvement in IR following weight loss.
Erythrocyte fatty acids, which were used as makers for
dietary exposure, have also been considered as a valid
proxy for fatty acid composition in the liver [15] and
adipose tissues [16] in human and most animal tissues [18].Materials and methods
Study population
Nondiabetic obese adults between 18 and 60 years of age
with a body mass index (BMI)  27 (nZ 35) were recruited
from the community to participate in a dietitian-led weight-
reduction program, inwhich the participantswere counseled
on how to reduce caloric intake following a low-fat diet. All
individuals with diabetes or taking antidiabetic drugs or who
had a history of cardiovascular or renal diseases, pregnancy,
or lactation were excluded. This study was approved by the
Human Ethics Committee of Kaohsiung Medical University.
All participants provided informed consent.Weight loss program
Obese participants were enrolled in a 12-week weight loss
program. Counseling and group classes were provided by
registered dietitians from a teaching hospital in southern
Taiwan. All participants were generally in good health as
evidenced by physical examination by physicians and
biochemical indicators. During the 12-week period, partic-
ipants met with dietitians every 1 or 2 weeks to receive
group nutrition and weight-control counseling. The main
dietary goal was to reduce calories and fat intake. The
enrollees were introduced to the topics of obesity and
health, the six major food groups, serving sizes, recognition
of foods high in nutrient density, calculation of fat content,
tips for light cooking, eating out, modifying holiday eating
habits, and understanding food labels. The participants
438 T.-N. Wang et al.kept food intake diaries that the dietitians reviewed during
every visit to discuss their eating habit modifications.
Anthropometric and biochemical measurements
Anthropometric measurements (weight, height, waist
circumference, and % of body fat) were taken at baseline
and at the end point of the weight-reduction program.
Percent of body fat was assessed by bioelectrical imped-
ance analysis using a Tanita body fat analyzer with a single
frequency of 50 kHz (Tanita BF-702; Tanita Corporation,
Tokyo, Japan). Trained interviewers helped the partici-
pants to complete a questionnaire, which collected demo-
graphic and lifestyle data.
At baseline and after the 12-week dietary counseling
period, routine laboratory workups were performed. After
fasting overnight, the participants provided venous blood
samples, which were sent to the Department of Laboratory
Medicine in KaohsiungMedical University Hospital for routine
clinical blood measurements including levels of triglyceride,
cholesterol, glutamate oxaloacetate transaminase (GOT),
glutamate pyruvate transaminase (GPT), uric acid, and
creatinine using an auto-analyzer (Beckman LX-20; Beckman
Coulter, Palo Alto, CA, USA). Fasting plasma glucose was
measured using Freestyle Blood Glucose Monitoring System
(Abbott Diabetes Care, Alameda, CA, USA). Insulin concen-
trations were analyzed using a radioimmunoassay kit (Coat-A
Count Insulin; Diagnostic Product Corporation, Los Angeles,
CA, USA). IR was then assessed using the homeostatic model
[homeostasis model assessment for insulin resistance
(HOMA-IR) Z insulin (mU/mL)  fasting plasma glucose
(mmol/L)/22.5] [19]. Leptin andghrelin concentrationswere
measured by a radioimmunoassay (LINCO Research, Inc., St.
Charles, MO, USA).
Fatty acid analysis by gas chromatography
Erythrocyte fatty acids were extracted following the
method described by Bligh and Dyer [20] and derivatized to
methyl ester using boron trifluorideemethanol. The meth-
ylated fatty acids (fatty acid methyl esters or FAME) were
quantified using a Hewlett-Packard 6890 Gas Chromato-
graph with a DB225-fused silica capillary column
(60  0.32 mm inner diameter with a film thickness of
0.25 mm) with N2 as the carrier gas. The injector temper-
ature was 250C and the carrier gas flow rate was 25 cm/
second. The oven temperature was initially set at 60C and
gradually increased at a rate of 10C/minute to 180C. This
temperature was maintained for 5 minutes and then ram-
ped at 3C/minute to 220C and held for 29 minutes.
Instrumental response factors were generated by running
an equal-weight FAME mixture (68A; Nu-Chek-Prep, Elysian,
MN, USA) along with samples. C17:0 was added to calculate
quantitative profiles of placental fatty acids. FAME analysis
by gas chromatography was performed using a modified
procedure [18].
Statistical analysis
Paired t test or Wilcoxon signed-rank test was used to test
the differences in changes (after weight loss minus beforeweight loss) of parametric or nonparametric parameters
following weight loss. Correlation between changes in
leptin levels and weight status was performed using Pear-
son correlation. Changes in dietary habits before and after
weight loss were assessed using McNemar’s test.
Changes in HOMA-IR levels less than zero between
postweight loss and preweight loss were classified as
improvement in HOMA-IR and changes in HOMA-IR levels
greater or equal to zero were classified as having no
improvement in HOMA-IR. Continuous data between
obese participants with and without HOMA-IR improve-
ments were compared using independent t test or Man-
neWhitney test. We used univariate logistic regression
analysis to identify parameters related to improvement
in HOMA-IR following weight loss. Multivariate logistic
regression model upon adjustment for age, gender, and
changes in body weight/body fat was used to assess the
relationships between leptin/ghrelin and to find out
whether there was an improvement in IR levels. All statis-
tical operations were performed using SPSS version 15.0. A
p value <0.05 was considered to be significantly different,
and p between 0.05 and 0.1 was considered to be margin-
ally significant.
Results
Effect of weight loss on metabolic variables, leptin/
ghrelin, and erythrocyte fatty acid profile in obese
participants
Approximately two-thirds of participants were female
(n Z 23). Thirteen out of the 23 female participants
answered whether they received estrogen therapy or took
contraception pill at the time of this surveillance. Two of
the participants were at menopausal stage and none of the
13 female participants were under estrogen therapy or took
contraception pills. After dietary counseling for weight
loss, obese patients had 6.2%, 6.2%, and 6.6% reductions in
body weight (81.0 vs. 86.6 kg, p < 0.001), BMI (30.5 vs.
32.6 kg/m2, p < 0.001), and % of body fat (38.8% vs.41.8%,
p < 0.001), respectively (Table 1). After stratifying by
gender, we found that males had greater decreases in body
weight (8.4 vs. 4.2 kg, p Z 0.001) and BMI (2.8 vs.
1.7 kg/m2 p Z 0.019) than females, while there was no
significant difference in body fat reduction between males
and females (4.6 vs. 2.3%, pZ 0.176) (data now shown).
Participants also had a significant reduction in HOMA-IR
(1.4 vs. 2.4, p Z 0.007) with a 16.7% improvement, and
significant improvements in systolic blood pressure, dia-
stolic blood pressure, GOT, GPT, triglyceride, and choles-
terol (all p < 0.05) following weight loss (Table 1). Leptin
levels decreased by 23.3% (12.9 vs.16.9 ng/mL, p < 0.001),
while ghrelin levels increased by 11.3% (867.8 vs. 796.1 pg/
mL, p Z 0.005) following weight loss (Table 2). Further-
more, we also found that the reduction in leptin levels
correlated with a reduction in body weight (r Z 0.44,
p Z 0.011), fat mass (r Z 0.46, p Z 0.007), and HOMA-IR
(r Z 0.42, p Z 0.014) based on Pearson correlation anal-
ysis (data not shown).
Participants also had a significant 2.8% reduction rate
in total saturates (41.12% vs. 42.38%, p Z 0.002),
Table 1 Changes in clinical parameters in obese adults following weight loss.a
Variables Obese participants
before weight
loss (n Z 35)
Obese participants
after weight
loss (n Z 35)
Change
after weight
loss (unit)
Change after
weight loss (%)
pb
Anthropometric measures
Body weight (kg) 86.6  20.2 81.0  18.3 5.6  3.8 6.2  3.8 <0.001
Body mass index (kg/m2) 32.6  5.1 30.5  4.7 2.1  1.3 6.2  3.8 <0.001
Body fat (%) 41.8  7.9 38.8  7.2 3.0  4.6 6.6  11.2 <0.001
Biochemical measures
Systolic blood pressure (mmHg) 122.5  13.6 106.1  11.0 16.4  10.0 13.0  7.4 <0.001
Diastolic blood pressure (mmHg) 79.2  8.3 69.2  8.2 10.0  7.0 12.3  8.4 <0.001
Glucose (mg/dL) 97.1  20.0 92.4  12.1 4.7  16.3 3.7  10.8 0.072
GOT (IU/L) 30.8  14.2 23.8  7.2 6.9  10.8 14.7  24.9 0.001
GPT (IU/L) 36.6  27.4 25.9  12.3 10.7  21.1 13.2  38.1 0.003
Triglyceride (mg/dL) 123.6  70.8 102.1  54.9 21.5  54.0 3.8  61.2 0.022
Total cholesterol (mg/dL) 182.0  26.8 161.7  27.8 20.4  23.1 10.8  11.5 <0.001
Creatinine (mg/dL) 0.8  0.2 0.8  0.1 0.0  0.1 1.7  13.1 0.672
Uric acid (mg/dL) 6.4  1.7 6.0  1.4 0.4  1.1 3.4  16.0 0.148
HOMA-IR 2.4  3.1 1.4  1.0 1.0  2.7 16.7  54.5 0.007
GOTZ glutamate oxaloacetate transaminase; GPTZ glutamate pyruvate transaminase; HOMA-IRZ homeostasis model assessment for
insulin resistance.
a Data are expressed as means  SD. A p value <0.05 was considered to be significantly different; p between 0.05 and 0.1 was
considered to be marginally significant.
b Paired t test or Wilcoxon signed-rank test was used to test the differences in changes (after weight loss minus before weight loss) of
parametric or nonparametric parameters following weight loss.
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(31.40% vs. 30.73%, p Z 0.088), and a significant 16.8%
increase in ne3 polyunsaturates (10.57% vs. 9.48%,
p Z 0.012). More specifically, there were significantTable 2 Changes in leptin, ghrelin, and erythrocyte fatty acid
Variables Obese participants
before weight
loss (n Z 35)
Obese p
after
loss (
Inflammatory factors
Leptin (ng/mL) 16.9  9.07 12.9
Ghrelin (pg/mL) 796.1  205.6 867.8
Erythrocyte fatty acid (wt.%)
Total saturates 42.38  2.05 41.12
Total monounsaturates 16.24  1.29 15.71
Total polyunsaturates 40.21  2.93 41.97
Total ne6 polyunsaturates 30.73  1.87 31.40
C18:2ne6 11.77  1.31 11.33
C20:3ne6 1.49  0.28 1.35
C20:4ne6 13.93  1.74 15.00
C22:4ne6 2.85  0.68 3.00
C22:5ne6 0.68  0.14 0.74
Total ne3 polyunsaturates 9.48  2.03 10.57
C18:3ne3 0.27  0.09 0.25
C20:5ne3 0.68  0.30 0.77
C22:5ne3 2.16  0.31 2.01
C22:6ne3 6.53  1.43 7.38
a Data are expressed as means  SD. A p value <0.05 was consid
considered to be marginally significant.
b Paired t test or Wilcoxon signed-rank test was used to test the diff
parametric or nonparametric parameters following weight loss.increases in polyunsaturates, including C20:4ne6,
C22:4ne6, and C22:6ne3 (all p < 0.05), and marginal
increases in C22:5ne6, and C22:5ne3 (p Z 0.053e0.083)
(Table 2).composition in obese adults after weight loss.a
articipants
weight
n Z 35)
Change
after weight
loss (unit)
Change
after weight
loss (%)
pb
 8.0 4.0  4.2 23.3  24.3 <0.001
 210.7 76.9  147.9 11.3  18.3 0.005
 1.27 1.26  2.26 2.8  5.0 0.002
 1.01 0.53  1.61 2.7  9.4 0.061
 1.81 1.76  3.63 5.0  10.1 0.007
 1.80 0.68  1.70 2.4  5.8 0.088
 1.37 0.44  1.17 3.4  10.3 0.018
 0.24 0.14  0.20 8.7  12.9 <0.001
 1.45 1.06  1.78 8.9  14.6 0.001
 0.67 0.14  0.35 6.2  14.2 0.033
 0.16 0.06  0.16 12.3  28.9 0.083
 1.97 1.08  2.42 16.8  36.6 0.012
 0.05 0.02  0.08 4.1  24.2 0.055
 0.41 0.10  0.29 17.3  52.4 0.132
 0.41 0.16  0.41 12.1  27.5 0.053
 1.43 0.85  1.85 19.8  41.9 0.010
ered to be significantly different; p between 0.05 and 0.1 was
erences in changes (after weight loss minus before weight loss) of
440 T.-N. Wang et al.Although we were unable to collect complete dietary
recall before and after weight loss and thus unable to
address changes in energy intake, we did assess dietary
habits related to reduced fat intakes. We examined
improvements in the reduced consumption of fat after
weight loss. Frequency of high-fat food consumption was
described on a five-point scale (always, often, sometimes,
seldom, and never). We further categorized these items
into dichotomous variables as frequent eating (always and
often) and less-frequent eating (sometimes, seldom, and
never). After receiving counseling, proportion of frequent
eating of poultry skin (p Z 0.004), beef/pork/lamb skin
(p < 0.001), and deep-fried fish (p Z 0.003) was signifi-
cantly decreased based on the analysis of McNemar’s test.
Besides, proportion of frequent eating of more than five
servings of fruit and vegetables per day was also increased
(p Z 0.022) following weight loss (data nor shown).
Therefore, reduced fat intake and frequent healthy eating
may be factors contributing to weight loss in our
participants.
Profiles of fasting leptin, ghrelin, and erythrocyte
fatty acids in IR-improved and unimproved obese
participants
There were no differences in age, gender, education (<6
vs. 6 years), smoking (yes vs. no), alcohol consumption
(yes vs. no), and exercise (yes vs. no) habits in participants
who had improvements in HOMA-IR levels and those who did
not (data not shown). Participants with improvements in
HOMA-IR levels had a significant reduction in leptin levels
(5.63  3.96 vs. 1.57  3.38 ng/mL, pZ 0.004, Table 3)
compared with those with no improvement in HOMA-IR
levels. Although increases in ghrelin were greater in the
HOMA-IR-improved group (114.54  102.61 vs.
31.16  182.71 pg/mL), the difference was not significantly
different (pZ 0.120, Table 3). Profiles of erythrocyte fattyTable 3 Relationships between changes in levels of leptin, ghr
insulin resistance improvement and no improvement following w
Variables No improvements
in HOMA-IR after
weight loss (n Z 15
HOMA-IR 0.35  0.61
Leptin (ng/mL) 1.57  3.38
Ghrelin (pg/mL) 31.16  182.71
Total saturates (wt.%) 1.38  1.34
Total monounsaturates (wt.%) 0.44  1.66
Total polyunsaturates (wt.%) 1.80  2.71
ne6 polyunsaturates (wt.%) 1.08  1.53
ne3 polyunsaturates (wt.%) 0.72  1.89
HOMA-IR Z homeostasis model assessment for insulin resistance.
a Data are expressed as means  SD. A p value <0.05 was consid
considered to be marginally significant.
b Changes of insulin resistance less than zero (postweight loss minu
group and changes of insulin resistance greater or equal to zero (po
no improvement in HOMA-IR.
c Differences between improvement and no improvement groups w
ables and using ManneWhitney U test for nonparametric variables.acids, including saturates, monounsaturates, and ne6/ne3
polyunsaturates were similar between the improvement
and no-improvement groups.
We performed a univariate analysis (data not shown) and
found increases in weight [odds ratio (OR) Z 0.86, 95%
confidence interval (CI)Z 0.69e1.06, pZ 0.160] or in % of
body fat (ORZ 0.89, 95% CIZ 0.75e1.06, pZ 0.199) after
weight loss correlated with less chance of HOMA-IR
improvements, though the difference was not significant.
The insignificant associations between weight/body fat
changes and improvements of HOMA-IR may be due to the
limited number of participants included in this study. After
adjusting for age, gender, change in ghrelin level, and
change in body fat % (Model 1) (Table 4), we found that
decreases in each unit of leptin correlated with less risk of
no improvements in HOMA-IR (OR Z 0.69, 95%
CI Z 0.49e0.98, p Z 0.039). Results were similar after
adjusting for body weight. Correlations between changes in
leptin and improvement in IR levels, however, only reached
marginal significance (Model 2: OR Z 0.70, 95%
CI Z 0.48e1.01; p Z 0.058).
Discussion
Participants receiving dietary counseling for weight loss had
a significant reduction in body weight, body fat, and HOMA-
IR (6.2%, 6.6%, and 16.7%, respectively). They also had
significant reductions (3.8e14.7%) in blood pressure, liver
function indicators (GOT/GPT), and blood lipids (choles-
terol and triglyceride). Our IR, weight loss, and metabolic
indicator findings were consistent with previous studies,
which reported that a 5e10% weight loss effectively
ameliorated the metabolic alterations induced by obesity
and some proinflammatory cytokines [4e6].
Obese individuals are often found to have hyper-
leptinemia, a state known as leptin resistance [8]. In this
study, a 6.2% weight loss reduced the serum leptin levels ofelin, and erythrocyte fatty acids between obese adults with
eight loss.a,b
)
Improvements
in HOMA-IR after
weight loss (n Z 20)
pc
2.00  3.12 <0.001
5.63  3.96 0.004
114.54  102.61 0.120
1.19  2.81 0.500
0.66  1.62 0.699
1.75  4.30 0.970
0.49  1.79 0.326
1.26  2.80 0.536
ered to be significantly different; p between 0.05 and 0.1 was
s preweight loss < 0) was classified as improvements in HOMA-IR
stweight loss minus preweight loss  0) was classified as having
ere tested using independent samples t test for parametric vari-
Table 4 Multivariate logistic regression analysis of associations between changes of leptin and improvement of insulin
resistance as HOMA-IR index in obese adults following weight loss (n Z 35).a,b
Variable Adjusted Model 1
OR (95% CI)
p Adjusted Model 2
OR (95% CI)
p
Age (y) 1.08 (0.97e1.20) 0.149 1.08 (0.97e1.19) 0.163
Gender (male) 0.77 (0.08e7.08) 0.815 0.81 (0.04e17.35) 0.895
Changes in leptin (ng/mL) 0.69 (0.49e0.98) 0.039 0.70 (0.48e1.01) 0.058
Changes in ghrelin (pg/mL) 1.00 (0.99e1.01) 0.660 1.00 (0.99e1.01) 0.644
Changes in body weight (kg) d d 0.96 (0.64e1.44) 0.848
Changes in body fat (%) 0.95 (0.76e1.19) 0.655 d d
CI Z confidence interval; HOMA-IR Z homeostasis model assessment for insulin resistance; OR Z odds ratio.
a Data are expressed as adjusted OR (odds ratio) and 95% CI (95% confidence interval). A p value <0.05 was considered to be signif-
icantly different; p between 0.05 and 0.1 was considered to be marginally significant.
b Changes of insulin resistance less than zero (postweight loss minus preweight loss < 0) was classified as improvements in HOMA-IR
group and changes of insulin resistance greater or equal to zero (postweight loss minus preweight loss  0) was classified as having
no improvement in HOMA-IR. Both model 1 and model 2 were adjusted for age, gender, changes in ghrelin and changes in body weight or
body fat.
Changes in leptin and HOMA-IR levels after weight loss 441these participants by 23.3%, while participants with
improvements in HOMA-IR levels had a significantly greater
reduction in leptin level than those with no improvement in
HOMA-IR levels (5.63 vs. 1.57 mg/dL). Weight loss
greatly reduced serum leptin levels. Our data were
consistent with other studies [4,5] showing that a 5e10%
weight loss can cause a 17e48% decrease in leptin levels.
Leptin is secreted primarily by the adipose tissue and is
parallel to body fat content [10,21]. Previous studies have
shown that weight gain augments leptin production [22]
and weight loss decreases levels of leptin [4,5] in humans.
Our finding of an association between decreases in leptin
and reduction in body weight or % of body fat in univariate
analysis was consistent with the earlier findings. Adiposity
can impact both leptin and insulin sensitivity [21]; leptin
has been implicated in the modulation of glucose homeo-
stasis and insulin sensitivity [10]. One intervention study
found that administration of leptin normalized the metab-
olism of glucose and insulin in obese individuals before they
began to lose weight, suggesting an association between
leptin and glucose metabolism independent from weight or
fat mass [9]. In this study, we adjusted for body fat changes
in our multivariable models and found that changes in
leptin after weight loss remained significantly associated
with improvement of HOMA-IR, confirming the independent
role of leptin changes in modulating IR [23,24].
In addition, we also found an 11.3% increase in serum
ghrelin level followingweight loss. Ghrelin levels decrease in
the stomach in response to fullness, signaling central nervous
system to inhibit the desire to eat [10]. The postprandial
suppression of ghrelin is considerably reduced in obese
adults [25]. In addition, short-term insulin infusions decrease
ghrelin concentrations in insulin-resistant adults relative to
equal-obese insulin sensitive controls [26]. In our investiga-
tion, participants inwhomHOMA-IR levels improved only had
similar ghrelin changes (p Z 0.120) compared with those
without such improvements. The reduced significance may
be due to the limited number of participants studied.
There is fewevidence showing that in healthymenopausal
population, low-dose hormone therapy may significantly
decrease leptin levels in cross-sectional and interventionstudies [27,28], and elevate ghrelin levels in cross-sectional
study [28]. Furthermore, in women with polycystic ovary
syndrome, oral contraceptive treatment is positively asso-
ciated with ghrelin concentrations but not with leptin [29].
Among the 23 female participants in our study, 13 reported
no use of estrogen and contraception pills, and 10 partici-
pants did not answer these questions. Therefore, we were
unable to examine the impact of hormone therapy on leptin
and ghrelin. More studies are needed to clarify the effects of
hormone therapy on leptin and ghrelin levels, and their
relations with IR and weight loss.
Nutrition counseling provided by dietitians was aimed at
educating our participants to reduce energy intakes and
choose foods or meals that were generally low in saturated
fat and rich in polyunsaturated fat. The participants had a
significant reduction in saturates, marginal increase in total
ne6, and significant increase in ne3 polyunsaturates in
erythrocyte. More specifically, long-chain polyunsaturates,
including 6, C20:4ne6, C22:4ne6, and C22:6ne3, were
significantly increased (all p < 0.05). Although we did not
study the accumulation of fatty acid at the tissue level, in
a study involving seven obese patients with nonalcoholic
fatty liver disease who lost 21% of their initial body weight
after receiving subtotal gastrectomies, the patients had an
81% increase in hepatic ne3 polyunsaturates and a 93%
increase in ne3 long-chain polyunsaturates, changes that
were mirrored in the measurement of these variables at the
erythrocyte level [15]. In another study, 21 obese partici-
pants receiving low-calorie low-fat diets for 6 months
had a mean weight loss of 5.1 kg and significant increases
(51%) in the accumulation of ne3 polyunsaturates (51%,
p Z 0.0001), mainly due to 75% increases in a long-chain
ne3 polyunsaturates, C22:6ne3, and 11% decreases in
saturates (p Z 0.0001) in muscle phospholipids [30]. That
study’s multivariate linear modeling found that changes in
ne3 polyunsaturates in phospholipid could independently
predict HOMA-IR levels. Other studies have postulated that
the altered desaturation and elongation of the ne3 essen-
tial fatty acids from 18-carbon precursor to the longer-
chain (C20eC22) metabolites in obese or diabetic individ-
uals may be due to the suppression of delta-6 and delta-5
442 T.-N. Wang et al.desaturase activities [31]. Our study did not find any
differences between the improvement group and the no-
improvement group in the accumulation of the fatty acids
at the erythrocyte level. The difference in our findings may
be due to duration of weight loss program, whether or not
there was ne3 polyunsaturated fatty acid supplementation,
differences in specimens analyzed, or methods used to
assess insulin sensitivities [15,17,21,30].
This study has some limitations. One limitation is that
our obese participants received nutrition counseling for
weight control, which is generally attributed to a low-fat
calorie-restricted diet. However, because some dietary
records were incomplete, we were unable to clarify the
impact of changes in specific dietary macronutrients and
micronutrients on improvements in IR after weight loss.
Research illustrates hypocaloric diets varying in macronu-
trient composition may interact with insulin dynamics to
influence weight loss success [32]. Another limitation was
that our intervention period was relatively short (12
weeks), and so we were unable to further examine the
influence of weight loss stabilization on various metabolic
and anthropometrics changes over longer periods.
In conclusion, a 6.2% reduction in weight over a short-
term period significantly improved IR in our patients. This
weight reduction concurrently decreased serum leptin and
increased serum ghrelin levels, as well as increased accu-
mulation of some longer-chain unsaturates. The indepen-
dent correlation between changes in leptin and
improvements in IR indicates that leptin may play some role
in modulating IR after moderate weight loss.Acknowledgement
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